- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Effect of High Altitude Exposure, Acclimatization and Re-exposure on Postural Control in Lowlanders (clinicaltrials.gov) - Jan 17, 2019 P=N/A, N=21, Completed, Recruiting --> Completed | Trial completion date: Dec 2018 --> May 2016 | Trial primary completion date: Dec 2018 --> May 2016 Recruiting --> Completed | Trial completion date: Dec 2018 --> May 2016 | Trial primary completion date: Dec 2018 --> May 2016
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Effect of High Altitude Exposure, Acclimatization and Re-exposure on Cerebral Autoregulation in Lowlanders (clinicaltrials.gov) - Jan 17, 2019 P=N/A, N=21, Completed, Recruiting --> Completed | Trial completion date: Dec 2018 --> May 2016 | Trial primary completion date: Dec 2018 --> May 2016 Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> May 2016 | Trial primary completion date: Dec 2018 --> May 2016
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Enrollment change: Acclimatization of Healthy Subjects During a Stay at 3200 m (clinicaltrials.gov) - Oct 30, 2018 P=N/A, N=20, Completed, Recruiting --> Completed | Trial completion date: Dec 2018 --> May 2016 | Trial primary completion date: Dec 2018 --> May 2016 Active, not recruiting --> Completed | N=10 --> 20
- |||||||||| Enrollment closed, Trial primary completion date: Acclimatization of Healthy Subjects During a Stay at 3200 m (clinicaltrials.gov) - May 25, 2017
P=N/A, N=10, Active, not recruiting, Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Dec 2018
- |||||||||| dexamethasone / Generic mfg.
Trial completion, Enrollment change: Altitude Related Illness In Patients With Respiratory Disease (clinicaltrials.gov) - May 17, 2017 P4, N=124, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Dec 2018 Recruiting --> Completed | N=90 --> 124
- |||||||||| Trial completion, Phase classification: MEDEX Hidden Valley 2008 (clinicaltrials.gov) - Mar 31, 2017
P=N/A, N=44, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P4 --> PN/A
- |||||||||| Enrollment change, Trial withdrawal, Trial primary completion date: Inhaled Budesonide for Altitude Illness Prevention (clinicaltrials.gov) - Mar 13, 2017
P3, N=0, Withdrawn, Active, not recruiting --> Completed | Phase classification: P4 --> PN/A N=100 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2017 --> Mar 2017
- |||||||||| acetazolamide / Generic mfg.
Trial completion, Trial primary completion date: AZ, MZ, and the Pulmonary System Response to Hypoxia (clinicaltrials.gov) - Oct 19, 2016 P4, N=14, Completed, Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Aug 2016
- |||||||||| Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca
Trial completion: Inhaled Budesonide and Acute Mountain Sickness (clinicaltrials.gov) - Oct 13, 2016 P1, N=51, Completed, Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Aug 2016 Recruiting --> Completed
- |||||||||| Enrollment closed, Enrollment change: Kyrgyz Asthma Rehabilitation at High Altitude (clinicaltrials.gov) - Aug 12, 2016
P=N/A, N=50, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=40 --> 50
|